dailyai.report

CEO Dario Amodei suggests AI will provide immediate, incremental gains in biotechnology despite widespread industry hype. The focus shifts from overnight cures to refining existing research workflows. This pragmatic approach means practitioners should expect steady efficiency improvements rather than sudden breakthroughs. It prioritizes iterative tool integration over speculative long-term promises from Anthropic.